Oncology Nursing News®

Blood Cancers

Expert Discusses Implant-Associated Lymphoma

Expert Discusses Implant-Associated Lymphoma

BY BRIELLE BENYON

FDA Grants ALPN-101 Orphan Drug Designations for GVHD Prevention, Treatment

FDA Grants ALPN-101 Orphan Drug Designations for GVHD Prevention, Treatment

BY JASON M. BRODERICK

Umbralisib Granted Orphan Drug Status for Follicular Lymphoma

Umbralisib Granted Orphan Drug Status for Follicular Lymphoma

BY JASON M. BRODERICK

What Defines Value-Based Cancer Care?

What Defines Value-Based Cancer Care?

BY STUART L. GOLDBERG, MD

A Chat About EMR Usage for CAR T-Cell Therapy

A Chat About EMR Usage for CAR T-Cell Therapy

BY BRIELLE BENYON

ASCO Issues Guidelines on Implant-Associated Lymphoma

ASCO Issues Guidelines on Implant-Associated Lymphoma

BY BRIELLE BENYON

FDA Approves Isatuximab-irfc for Previously Treated Myeloma

FDA Approves Isatuximab-irfc for Previously Treated Myeloma

BY BRIELLE BENYON

FDA Grants Priority Review to Tafasitamab/Lenalidomide Combination for DLBCL

FDA Grants Priority Review to Tafasitamab/Lenalidomide Combination for DLBCL

BY HANNAH SLATER

More Work Needed to Determine Best Treatment for High-Risk Myeloma

More Work Needed to Determine Best Treatment for High-Risk Myeloma

BY ELLIE LEICK

Expert Discusses Advances, Unmet Needs in GVHD Treatment

Expert Discusses Advances, Unmet Needs in GVHD Treatment

BY BRIELLE BENYON

External Resources

MJH Associates
American Journal of Managed Care
Cure
MD Magazine
Pharmacy Times
Physicians' Education Resource
Specialty Pharmacy Times
TargetedOnc

OncNurse Resources

Newsroom
Continuing Education
Discussions
Web Exclusives

About Us
Advertise
Advisory Board
Careers
Contact Us
Privacy Policy
Terms & Conditions

Intellisphere, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747

Copyright OncNursing 2006-2019
Intellisphere, LLC. All Rights Reserved.